DBS of thalamic centromedian nucleus for Lennox-Gastaut syndrome (ESTEL trial).
Linda J DalicAaron E L WarrenKristian J BullussWesley ThevathasanAnnie RotenLeonid ChurilovJohn S ArcherPublished in: Annals of neurology (2021)
CM-DBS in patients with LGS reduced electrographic rather than diary-recorded seizures, after three-months of stimulation. 50% of all participants had diary-recorded seizures reduced by half at study exit, providing supporting evidence of treatment effect. This article is protected by copyright. All rights reserved.